LABORATORY CORPORATION OF AMERICA HOLDINGS Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.4 USD | +1.30% |
|
+4.64% | -7.44% |
Presenter SpeechAdam Schechter (Executives)All right. Thank you, A.J. Good afternoon, everybod...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows:
- clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services;
- development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies.
Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
2024-05-14
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
207.7
USD
Average target price
239.6
USD
Spread / Average Target
+15.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -7.44% | 17.51B | |
| +17.18% | 85.55B | |
| -28.48% | 70.07B | |
| +6.76% | 28.95B | |
| +2.14% | 17.39B | |
| +2.10% | 15.38B | |
| +7.02% | 13.4B | |
| +64.96% | 12.93B | |
| +6.64% | 12.77B | |
| +66.89% | 12.42B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- Transcript : Laboratory Corporation of America Holdings Presents at 30th Annual Credit Suisse Healthcare Conference, Nov-09-2021 01